-
-
The FDA has approved a buccal formulation of Acyclovir for the treatment of recurrent cold scores. The product uses a mucoadhesive technology that delivers the drug in high concentration to the site of the cold sore. Acyclovir buccal tablets are manufactured by Farmea in France and marketed as Sitavig by BioAlliance Pharma.
-
The authors concluded that in CAD patients, a history of CVE increased the risk of subsequent cardiovascular events, including hemorrhagic stroke.
-
A systematic review and meta-analysis of 50 randomized controlled trials did not find that vitamin and antioxidant supplements reduce the risk of cardiovascular disease. Numerous subgroup analyses similarly found no benefit from daily supplementation, but also no adverse effects.
-
Over the past few years, we have learned that seemingly minor injuries can cause significant morbidity and, in some cases, even contribute to mortality. Astute emergency providers have learned to look beyond minor complaints and watch for signs of significant problems. Mild traumatic brain injury or concussion is one of the best examples of an injury that has been often dismissed. Post-concussive syndrome was overlooked for many years. Athletes in particular are prone to repeated injury, which we now know contributes to later cognitive impairment and even in some cases death.
-
-
Are OSA Outcomes Better in the Hands of Sleep Specialists than Primary Care Clinicians?; Inhaled Steroids Increase Risk of TB in COPD Patients
-
-
More patients who received a preventive medicine intervention also had their physician receive the corresponding preventive intervention.
-
Mediterranean Diet Can Reduce Risk for Stroke; Low Levels of Light Exposure Associated with Higher Stroke Incidence